Device type · MOF
Guide, Wire, Catheter, Neurovasculature
Last checked: Nov 19, 2026Source: openFDAMethods & limitations
Product code
MOF
Neurology
Device class
Class II
FDA decisions since 2015
41
510(k), De Novo and PMA
Adverse event reports
182
Received Nov 1, 2025 to Nov 19, 2026
How FDA classifies it
- Device type
- Guide, Wire, Catheter, Neurovasculature
- Product code
- MOF
- Device class
- Class II
- Review panel
- Neurology
- Regulation
- 21 CFR 870.1330
- Specialty
- Neurology & Neurosurgery
- FDA record
- Classification database entry for MOF
Latest FDA decisions
The 8 newest of 41 since 2015.
- Aristotle 65 Macrowire510(k)
K254181 · Decided Sep 16, 2026 · 267 days after receipt
Device type: Guide, Wire, Catheter, Neurovasculature (MOF) · Cardiology
- 35 Helix Guidewire510(k)
K260751 · Decided Aug 27, 2026 · 174 days after receipt
Device type: Guide, Wire, Catheter, Neurovasculature (MOF) · Cardiology
- Willow 12 Guidewire510(k)
K262424 · Decided Aug 14, 2026 · 29 days after receipt
Device type: Guide, Wire, Catheter, Neurovasculature (MOF) · Cardiology
38 more FDA decisions with a free account
Reports received
182
Received Nov 1, 2025 to Nov 19, 2026. Includes 2 of another or unstated type.
Malfunction reports
146
80% of reports
Injury reports
33
18% of reports
Death reports
1
0.5% of reports
Adverse event reports received per month
By the date FDA received each report, stacked by event type. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 5 | 2 | 0 | 0 |
| Jan 24 | 2 | 2 | 0 | 0 |
| Feb 24 | 7 | 2 | 0 | 0 |
| Mar 24 | 4 | 2 | 0 | 0 |
| Apr 24 | 3 | 5 | 0 | 0 |
| May 24 | 4 | 2 | 0 | 0 |
| Jun 24 | 4 | 3 | 0 | 0 |
| Jul 24 | 6 | 3 | 1 | 0 |
| Aug 24 | 9 | 5 | 1 | 0 |
| Sep 24 | 5 | 2 | 0 | 0 |
| Oct 24 | 8 | 3 | 0 | 0 |
| Nov 24 | 3 | 1 | 0 | 0 |
| Dec 24 | 4 | 4 | 0 | 0 |
| Jan 25 | 12 | 1 | 0 | 0 |
| Feb 25 | 7 | 2 | 0 | 0 |
| Mar 25 | 10 | 2 | 0 | 0 |
| Apr 25 | 7 | 2 | 0 | 0 |
| May 25 | 5 | 3 | 0 | 0 |
| Jun 25 | 6 | 1 | 1 | 0 |
| Jul 25 | 15 | 3 | 0 | 0 |
| Aug 25 | 10 | 2 | 0 | 0 |
| Sep 25 | 10 | 1 | 0 | 0 |
| Oct 25 | 5 | 3 | 0 | 0 |
| Nov 25 | 7 | 2 | 0 | 0 |
| Dec 25 | 17 | 3 | 0 | 0 |
| Jan 26 | 12 | 3 | 0 | 0 |
| Feb 26 | 42 | 4 | 1 | 0 |
| Mar 26 | 16 | 1 | 0 | 0 |
| Apr 26 | 13 | 1 | 0 | 0 |
| May 26 | 6 | 4 | 0 | 0 |
| Jun 26 | 11 | 7 | 0 | 0 |
| Jul 26 | 9 | 2 | 0 | 0 |
| Aug 26 | 4 | 2 | 0 | 0 |
| Sep 26 | 4 | 1 | 0 | 1 |
| Oct 26 | 5 | 3 | 0 | 1 |
| Nov 26 | 0 | 0 | 0 | 0 |
Manufacturers named most often
Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.
- Stryker94
4 more in this ranking with a free account
Device problems as coded
Last 12 months. FDA's terms. A report can carry several.
- Fracture79
- Break52
- Failure to Advance22
7 more in this ranking with a free account
Patient problems as coded
Last 12 months. FDA's terms. A report can carry several.
- No Clinical Signs, Symptoms or Conditions163
- Foreign Body In Patient8
- Insufficient Information4
7 more in this ranking with a free account
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-1940-2024 · Started Apr 18, 2024 · Posted by FDA May 31, 2024
Reason given: Stryker Neurovascular has observed an increased frequency of PTFE coating damage occurring on the Synchro Guidewires that may be caused by the practice of backloading the guidewire through the optional introducer accessory. This issue is limited to certain lots of the Synchro Guidewire that contain an older version of...
Cause as FDA categorized it: Component design/selection
Z-3103-2017 · Started Aug 7, 2017
Reason given: There is a potential for the hydrophilic coating on the guidewire to delaminate from the guidewire.
Cause as FDA categorized it: Under Investigation by firm
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.